Invesco Ltd. Cassava Sciences Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Invesco Ltd. holds 306,290 shares of SAVA stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

306,290

Previous 14,771 1973.59%

Holding current value

$1.17 Million

Previous $182,000 4852.75%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$9.57 - $35.08 $2.79 Million - $10.2 Million	291,519 Added 1973.59%	306,290 $9.01 Million
Q2 2024 Aug 13, 2024	BUY	$12.35 - $26.11 $6,841 - $14,464	554 Added 3.9%	14,771 $182,000
Q1 2024 May 14, 2024	SELL	$18.44 - $26.41 $1.13 Million - $1.62 Million	-61,275 Reduced 81.17%	14,217 $288,000
Q4 2023 Feb 12, 2024	BUY	$12.64 - $30.11 $741,702 - $1.77 Million	58,679 Added 349.01%	75,492 $1.7 Million
Q3 2023 Nov 13, 2023	SELL	$16.64 - $25.32 $5,940 - $9,039	-357 Reduced 2.08%	16,813 $279,000
Q2 2023 Aug 11, 2023	SELL	$21.59 - $27.88 $6.01 Million - $7.76 Million	-278,452 Reduced 94.19%	17,170 $421,000
Q1 2023 May 12, 2023	SELL	$23.46 - $36.44 $2.92 Million - $4.54 Million	-124,668 Reduced 29.66%	295,622 $7.13 Million
Q4 2022 Feb 13, 2023	BUY	$27.82 - $44.16 $4.57 Million - $7.25 Million	164,203 Added 64.12%	420,290 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $3.92 Million - $12.3 Million	240,355 Added 1527.81%	256,087 $10.7 Million
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $8,420 - $18,811	-489 Reduced 3.01%	15,732 $442,000
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $11,149 - $18,143	-342 Reduced 2.06%	16,221 $602,000
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $58,023 - $143,455	-1,578 Reduced 8.7%	16,563 $723,000
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $6.47 Million - $21 Million	-154,923 Reduced 89.52%	18,141 $1.13 Million
Q2 2021 Aug 17, 2021	BUY	$32.15 - $89.72 $4.94 Million - $13.8 Million	153,686 Added 793.1%	173,064 $14.8 Million
Q1 2021 May 17, 2021	BUY	$7.09 - $87.95 $49,069 - $608,701	6,921 Added 55.56%	19,378 $871,000
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $84,583 - $152,598	12,457 New	12,457 $85,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $154M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account